International Journal of Clinical Pharmacy

, Volume 36, Issue 3, pp 503–512 | Cite as

Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand

  • Ernieda HatahEmail author
  • June Tordoff
  • Stephen B. Duffull
  • Claire Cameron
  • Rhiannon Braund
Research Article


Background Poor adherence to medication can lead to suboptimal outcomes, and is reported to occur frequently. Pharmacists in some countries are funded to support the appropriate use of medications in patients and enhance medication adherence, by providing services such as Medicines Use Review (MUR). Objective To describe and investigate factors that may influence patients’ knowledge and perceptions of and adherence to medications as determined during MUR. Setting Community pharmacies in a locality in New Zealand. Method Following consent from five MUR service providers, records of patients’ MUR consultations conducted between November 2007 and December 2011 were retrospectively reviewed for information on patients, services, and outcomes. Using multilevel mixed-effects logistic regression, factors that predicted the providers’ score of the patients’ medication knowledge, and the patients’ score of their adherence to and perceptions of medications, were investigated. Main outcome measure patients’ knowledge, perceptions and adherence scores. Results A total of 353 MUR patients’ records were evaluated. The median (IQR) age of patients was 73 (63–81) years. About 41.1 % of patients were Māori. A total of 204 (57.8 %) patients had two MUR consultations and only 53 (15 %) had four. The mean score of patients’ knowledge, perceptions of, and adherence to medications were found to increase in each visit which suggests that adherence support by pharmacists might improve patients’ outcomes. Females had higher medication knowledge scores than males (OR 3.09, 95 % CI 1.29–7.44). There was some evidence to suggest Māori had lower scores for knowledge of medications than non-Māori (OR 0.092, 95 % CI 0.02–0.36). In addition, longer duration in the program predicted better scores for medication knowledge, adherence and perceptions of medications. Conclusions MUR was found to have the potential to improve the scores of patients’ knowledge and perceptions of and adherence to medicines, and factors such as gender, ethnicity and longer duration in the services were found to predict these outcomes.


Community pharmacy services Medication adherence Medication knowledge Medication review New Zealand Pharmaceutical care services Pharmacists 



We would like to thank the MUR coordinator and the community pharmacists who participated in this study and helped us with the data collections.


Funding for this study was provided by the School of Pharmacy, University of Otago. EH was supported by scholarship from Universiti Kebangsaan Malaysia and Ministry of Higher Education Malaysia.

Conflicts of interest

None to declare.


  1. 1.
    Ho P, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–35.PubMedCrossRefGoogle Scholar
  2. 2.
    World Health Organization. Adherence to long-term therapies: evidence for action, 2003. [cited 2013 Aug 24].
  3. 3.
    New England Health Institute. Thinking outside the pillbox: A system-wide approach to improving patient medication adherence for chronic disease, 2009. [cited 2013 Aug 24].
  4. 4.
    Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90.PubMedGoogle Scholar
  5. 5.
    Clyne W, Blenkinsopp A and Seal R. A Guide to Medication Review, 2008. [cited 2013 Aug 24].
  6. 6.
    District Health Board New Zealand. New Zealand National Pharmacist Services Framework, 2007. [cited 2013 Aug 24].
  7. 7.
    District Health Board Shared Services. New Zealand National Pharmacist Services Framework, 2007. [cited 2013 Aug 24].
  8. 8.
    Brandt T, Harrison J, Sheridan J, Shaw J, Jensen M. The evaluation of auckland District Health Board’s medicines use review pilot: the ADMiRE Report, 2009. [cited 2013 Aug 24].
  9. 9.
    Lee E, Braund R, Tordoff J. Examining the first year of medicines use review services provided by pharmacist in New Zealand. N Z Med J. 2009;122(1293):26–35.Google Scholar
  10. 10.
    Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the patient centered approach to medication management. 3rd ed. The United States of America: McGraw-Hill companies; 2012. ISBN 978-0-07-179086-4.Google Scholar
  11. 11.
    Asam L, Boardman HF, Pollock K. Understanding the patient perspective of the english community pharmacy medicines use review (MUR). Res Soc Admin. 2013;9:949–57.CrossRefGoogle Scholar
  12. 12.
    Statistics New Zealand, 2006 Census. [cited 2013 Aug 24].
  13. 13.
    Hatah E, Tordoff J, Duffull S, Braund R. Pharmacists’ performance of clinical interventions during adherence support medication reviews. Res in Soc and Admin Pharm (article in press).
  14. 14.
    StataCorp. Stata Statistical Software: Release 12, StataCorp LP2011: College Station, TX.Google Scholar
  15. 15.
    Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol. 2000;56(6–7):501–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Tordoff JM, Bagge ML, Gray AR, Campbell AJ, Norris PT. Medicine-taking practices in community-dwelling people aged > or = 75 years in New Zealand. Age Ageing. 2010;39(5):574–80.PubMedCrossRefGoogle Scholar
  17. 17.
    Guaraldo L, Cano FG, Damasceno GS, Rozenfeld S. Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatr. 2011;11(1):79.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013;7:525–30.PubMedCentralPubMedGoogle Scholar
  19. 19.
    Krien SL, Heisler M, Piette JD, Makki F, Kerr EA. The effect of chronic pain on diabetes patients’ self-management. Diabetes Care. 2005;28(1):65–70.CrossRefGoogle Scholar
  20. 20.
    Witticke D, Seidling H, Lohmann K, Send A, Haefeli W. Opportunities to reduce medication complexity: a retrospective analysis of patients discharged from a university hospital in Germany. Drug Saf. 2013;36(1):31–41.PubMedCrossRefGoogle Scholar
  21. 21.
    Lam PW, Lum CM, Leung MF. Drug non-adherence and associated risk factors among Chinese geriatric patients in Hong Kong. Hong Kong Med J. 2007;13(4):284–92.PubMedGoogle Scholar
  22. 22.
    Burge S, White D, Bajorek E, Bazaldua O, Trevino J, Albright T, et al. Correlates of medication knowledge and adherence: findings from the residency research network of South Texas. Fam Med. 2005;37(10):712–8.PubMedGoogle Scholar
  23. 23.
    Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14(5):267–73.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Kalichman SC, Rompa D. Functional health literacy is associated with health status and health-related knowledge in people living with HIV-AIDS. J Acquir Immune Defic Syndr. 2000;25(4):337–44.PubMedCrossRefGoogle Scholar
  25. 25.
    Ministry of Health New Zealand. Health literacy and Maori results from the 2006 adult literacy and life skills survey. [cited 2013 Aug 24].
  26. 26.
    Erickson S, Slaughter R, Halapy H. Pharmacists’ ability to influence outcomes of hypertension therapy. Pharmacother. 1997;17(1):140–7.Google Scholar
  27. 27.
    Hawkins D, Bradberry JC, Cziraky MJ, Talbert RL, Bartels DW, Cerveny JD. National pharmacy cardiovascular council treatment guidelines for the management of Type 2 diabetes Mellitus: toward better patient outcomes and new roles for pharmacists. Pharmacother. 2002;22(4):436–44.CrossRefGoogle Scholar
  28. 28.
    Al-Qazaz H, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33(6):1028–35.PubMedCrossRefGoogle Scholar
  29. 29.
    Coulter A, Parsons S and Askham J. Policy brief: where are the patients in decision-making about their own care?, 2008. [cited 2013 Aug 24].
  30. 30.
    Fairman K and Motheral B. Evaluating medication adherence: which measure is right for your program? J Managed Care Pharmacy. 2000;6(6):499-504.Google Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Ernieda Hatah
    • 1
    • 2
    Email author
  • June Tordoff
    • 1
  • Stephen B. Duffull
    • 1
  • Claire Cameron
    • 3
  • Rhiannon Braund
    • 1
  1. 1.School of PharmacyUniversity of OtagoDunedinNew Zealand
  2. 2.Faculty of PharmacyUniversiti Kebangsaan MalaysiaKuala LumpurMalaysia
  3. 3.Preventive and Social Medicine, Dunedin School of MedicineUniversity of OtagoDunedinNew Zealand

Personalised recommendations